Reuters logo
BRIEF-Miragen Therapeutics reports third quarter financial results
November 8, 2017 / 10:06 PM / a month ago

BRIEF-Miragen Therapeutics reports third quarter financial results

Nov 8 (Reuters) - Miragen Therapeutics Inc

* Miragen Therapeutics reports third quarter 2017 financial results and provides corporate update

* Q3 revenue $1.6 million versus $900,000

* Q3 revenue view $306,000 -- Thomson Reuters I/B/E/S

* Miragen Therapeutics Inc - ‍cash and cash equivalents at september 30, 2017 were $42.8 million, compared to $22.1 million at December 31, 2016​

* Miragen Therapeutics Inc - qtrly ‍net loss per share, basic and diluted $0.27​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below